A phase II study of single-agent RO4929097, a...

Gynecologic Oncology 2015 / 05 Vol. 137; Iss. 2

A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia

Diaz-Padilla, Ivan, Wilson, Michelle K., Clarke, Blaise A., Hirte, Hal W., Welch, Stephen A., Mackay, Helen J., Biagi, Jim J., Reedijk, Michael, Weberpals, Johanne I., Fleming, Gini F., Wang, Lisa, Li
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.03.005
Date:
May, 2015
File:
PDF, 771 KB
english, 2015
Conversion to is in progress
Conversion to is failed